Sales of the new medicine, called Orencia, may top $1 billion a year, some industry analysts have predicted.
Bristol-Myers shares, which closed at $22.94 on the New York Stock Exchange, were 4.6 percent higher at $24 in after-hours trading.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!